Clinical trial Recruiting at 1 site Observational Ages 20 to 70

AI tool to measure jaw, neck, and shoulder movement for oral cancer care

Official title: Validity and Reliability of an AI-based Physiotherapy Evaluation System for Oromandibular and Neck-Shoulder Range of Motion in Oral Cancer Patients

Run by National Taiwan University Hospital · NCT07509619 · Data updated 2026-11-12

This project tests an AI system that automatically measures jaw, neck, and shoulder movement for people with or recovering from oral cancer and compares its readings to manual measurements.

More Oral Cancer trials

Quick facts

Study typeObservational
Ages20 Years to 70 Years
SexAll
Enrollment20 (estimated)
SponsorNational Taiwan University Hospital
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Taipei)
StatusRecruiting
StartedApril 7, 2026
Main results expectedMay 31, 2026
Study endsDecember 31, 2027
Registry record updatedApril 13, 2026
Trial IDNCT07509619 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

This validation phase enrolls healthy adults aged 20–70 who have no trismus, no history of head/neck/shoulder injury or surgery, and no prior head and neck cancer treatments.

Probably not a fit

People with trismus, recent head/neck/shoulder surgery, active head and neck cancer treatment, or inability to follow instructions are unlikely to benefit from this validation study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This cross-sectional measurement study uses healthy adults aged 20–70 to validate an AI-based physiotherapy evaluation system for oromandibular and neck-shoulder range of motion. Participants perform standardized mouth opening and cervical/shoulder movements while the AI records real-time keypoints and calculates angles. Each movement is measured three times by the AI and independently by two blinded human raters using goniometers or a TheraBite scale, with the order of methods randomized. Reliability will be measured with intraclass correlation coefficients and agreement checked with Bland-Altman analysis and mean absolute error.

Why it matters

Potential benefit: If successful, the AI tool could provide faster, more objective, and more consistent range-of-motion measurements to support rehab for people with oral cancer.

How similar studies have gone: AI keypoint-tracking approaches have shown promising reliability for other musculoskeletal ROM measurements, but application specifically to oromandibular movement in oral cancer care is less well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Healthy adults aged 20 to 70 years
* No trismus
* No history of head, neck, or shoulder injury or surgery
* No history of head and neck cancer-related radiotherapy or chemotherapy

Exclusion Criteria:

* Inability to communicate or follow instructions
* Any condition that may affect movement performance

Where it's running

  • School and Graduate Institute of Physical Therapy, College of Medicine, National Taiwan University
    Taipei, Taiwan
    Recruiting

Study contacts

  • Principal investigator: Yueh-Hsia Chen, Ph.D. — School and Graduate Institute of Physical Therapy, College of Medicine, National Taiwan University
  • Study coordinator: Yueh-Hsia Chen, Ph.D.
  • Email: yuehhsiachen@ntu.edu.tw
  • Phone: +886-2-33668133

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.